Targeting the fatty acid biosynthesis enzyme, β-ketoacyl - Acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents

Patricia J. Lee, Jayendra B. Bhonsle, Heather W. Gaona, Donald P. Huddler, Tiffany N. Heady, Mara Kreishman-Deitrick, Apurba Bhattacharjee, William F. McCalmont, Lucia Gerena, Miriam Lopez-Sanchez, Norma E. Roncal, Thomas H. Hudson, Jacob D. Johnson, Sean Taylor Prigge, Norman C. Waters

Research output: Contribution to journalArticle

Abstract

The importance of fatty acids to the human malaria parasite, Plasmodium falciparum, and differences due to a type I fatty acid synthesis (FAS) pathway in the parasite, make it an attractive drug target. In the present study, we developed and a utilized a pharmacophore to select compounds for testing against PfKASIII, the initiating enzyme of FAS. This effort identified several PfKASIII inhibitors that grouped into various chemical classes of sulfides, sulfonamides, and sulfonyls. Approximately 60% of the submicromolar inhibitors of PfKASIII inhibited in vitro growth of the malaria parasite. These compounds inhibited both drug sensitive and resistant parasites and testing against a mammalian cell line revealed an encouraging in vitro therapeutic index for the most active compounds. Docking studies into the active site of PfKASIII suggest a potential binding mode that exploits amino acid residues at the mouth of the substrate tunnel.

Original languageEnglish (US)
Pages (from-to)952-963
Number of pages12
JournalJournal of Medicinal Chemistry
Volume52
Issue number4
DOIs
StatePublished - Feb 26 2009

Fingerprint

holo-(acyl-carrier-protein) synthase
Antimalarials
Parasites
Fatty Acids
Enzymes
Falciparum Malaria
Sulfonamides
Sulfides
Pharmaceutical Preparations
Malaria
Mouth
Catalytic Domain
Amino Acids
Cell Line
Growth

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Targeting the fatty acid biosynthesis enzyme, β-ketoacyl - Acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents. / Lee, Patricia J.; Bhonsle, Jayendra B.; Gaona, Heather W.; Huddler, Donald P.; Heady, Tiffany N.; Kreishman-Deitrick, Mara; Bhattacharjee, Apurba; McCalmont, William F.; Gerena, Lucia; Lopez-Sanchez, Miriam; Roncal, Norma E.; Hudson, Thomas H.; Johnson, Jacob D.; Prigge, Sean Taylor; Waters, Norman C.

In: Journal of Medicinal Chemistry, Vol. 52, No. 4, 26.02.2009, p. 952-963.

Research output: Contribution to journalArticle

Lee, PJ, Bhonsle, JB, Gaona, HW, Huddler, DP, Heady, TN, Kreishman-Deitrick, M, Bhattacharjee, A, McCalmont, WF, Gerena, L, Lopez-Sanchez, M, Roncal, NE, Hudson, TH, Johnson, JD, Prigge, ST & Waters, NC 2009, 'Targeting the fatty acid biosynthesis enzyme, β-ketoacyl - Acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents', Journal of Medicinal Chemistry, vol. 52, no. 4, pp. 952-963. https://doi.org/10.1021/jm8008103
Lee, Patricia J. ; Bhonsle, Jayendra B. ; Gaona, Heather W. ; Huddler, Donald P. ; Heady, Tiffany N. ; Kreishman-Deitrick, Mara ; Bhattacharjee, Apurba ; McCalmont, William F. ; Gerena, Lucia ; Lopez-Sanchez, Miriam ; Roncal, Norma E. ; Hudson, Thomas H. ; Johnson, Jacob D. ; Prigge, Sean Taylor ; Waters, Norman C. / Targeting the fatty acid biosynthesis enzyme, β-ketoacyl - Acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents. In: Journal of Medicinal Chemistry. 2009 ; Vol. 52, No. 4. pp. 952-963.
@article{3634c23ef0bb4c5c84d87e3b010c8b33,
title = "Targeting the fatty acid biosynthesis enzyme, β-ketoacyl - Acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents",
abstract = "The importance of fatty acids to the human malaria parasite, Plasmodium falciparum, and differences due to a type I fatty acid synthesis (FAS) pathway in the parasite, make it an attractive drug target. In the present study, we developed and a utilized a pharmacophore to select compounds for testing against PfKASIII, the initiating enzyme of FAS. This effort identified several PfKASIII inhibitors that grouped into various chemical classes of sulfides, sulfonamides, and sulfonyls. Approximately 60{\%} of the submicromolar inhibitors of PfKASIII inhibited in vitro growth of the malaria parasite. These compounds inhibited both drug sensitive and resistant parasites and testing against a mammalian cell line revealed an encouraging in vitro therapeutic index for the most active compounds. Docking studies into the active site of PfKASIII suggest a potential binding mode that exploits amino acid residues at the mouth of the substrate tunnel.",
author = "Lee, {Patricia J.} and Bhonsle, {Jayendra B.} and Gaona, {Heather W.} and Huddler, {Donald P.} and Heady, {Tiffany N.} and Mara Kreishman-Deitrick and Apurba Bhattacharjee and McCalmont, {William F.} and Lucia Gerena and Miriam Lopez-Sanchez and Roncal, {Norma E.} and Hudson, {Thomas H.} and Johnson, {Jacob D.} and Prigge, {Sean Taylor} and Waters, {Norman C.}",
year = "2009",
month = "2",
day = "26",
doi = "10.1021/jm8008103",
language = "English (US)",
volume = "52",
pages = "952--963",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Targeting the fatty acid biosynthesis enzyme, β-ketoacyl - Acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents

AU - Lee, Patricia J.

AU - Bhonsle, Jayendra B.

AU - Gaona, Heather W.

AU - Huddler, Donald P.

AU - Heady, Tiffany N.

AU - Kreishman-Deitrick, Mara

AU - Bhattacharjee, Apurba

AU - McCalmont, William F.

AU - Gerena, Lucia

AU - Lopez-Sanchez, Miriam

AU - Roncal, Norma E.

AU - Hudson, Thomas H.

AU - Johnson, Jacob D.

AU - Prigge, Sean Taylor

AU - Waters, Norman C.

PY - 2009/2/26

Y1 - 2009/2/26

N2 - The importance of fatty acids to the human malaria parasite, Plasmodium falciparum, and differences due to a type I fatty acid synthesis (FAS) pathway in the parasite, make it an attractive drug target. In the present study, we developed and a utilized a pharmacophore to select compounds for testing against PfKASIII, the initiating enzyme of FAS. This effort identified several PfKASIII inhibitors that grouped into various chemical classes of sulfides, sulfonamides, and sulfonyls. Approximately 60% of the submicromolar inhibitors of PfKASIII inhibited in vitro growth of the malaria parasite. These compounds inhibited both drug sensitive and resistant parasites and testing against a mammalian cell line revealed an encouraging in vitro therapeutic index for the most active compounds. Docking studies into the active site of PfKASIII suggest a potential binding mode that exploits amino acid residues at the mouth of the substrate tunnel.

AB - The importance of fatty acids to the human malaria parasite, Plasmodium falciparum, and differences due to a type I fatty acid synthesis (FAS) pathway in the parasite, make it an attractive drug target. In the present study, we developed and a utilized a pharmacophore to select compounds for testing against PfKASIII, the initiating enzyme of FAS. This effort identified several PfKASIII inhibitors that grouped into various chemical classes of sulfides, sulfonamides, and sulfonyls. Approximately 60% of the submicromolar inhibitors of PfKASIII inhibited in vitro growth of the malaria parasite. These compounds inhibited both drug sensitive and resistant parasites and testing against a mammalian cell line revealed an encouraging in vitro therapeutic index for the most active compounds. Docking studies into the active site of PfKASIII suggest a potential binding mode that exploits amino acid residues at the mouth of the substrate tunnel.

UR - http://www.scopus.com/inward/record.url?scp=64349090650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64349090650&partnerID=8YFLogxK

U2 - 10.1021/jm8008103

DO - 10.1021/jm8008103

M3 - Article

C2 - 19191586

AN - SCOPUS:64349090650

VL - 52

SP - 952

EP - 963

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 4

ER -